Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of Influenza Vaccination in Heart Failure (FLU-HF)
NCT05507502Unknown
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of influenza vaccine in influenza (2 arms). Primary endpoint: Seroconversion for one or more strains in the influenza vaccine at 1 month. Status: unknown.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05507502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05507502.